Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system. Recent developments have led to newer therapeutic options for disease treatment. A few studies have reported MS prevalence rates between 12 and 20 per 100,000 inhabitants nationwide in Argentina, and an incidence of 1.76...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas, Juan I, Patrucco, Liliana, Cristiano, Edgardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337150/
https://www.ncbi.nlm.nih.gov/pubmed/32669904
http://dx.doi.org/10.2147/DNND.S46557
Descripción
Sumario:Multiple sclerosis (MS) is an autoimmune disease of the central nervous system. Recent developments have led to newer therapeutic options for disease treatment. A few studies have reported MS prevalence rates between 12 and 20 per 100,000 inhabitants nationwide in Argentina, and an incidence of 1.76 cases per 100,000 inhabitants per year. Considering the epidemiology of MS in Argentina, the total number of patients affected is estimated at 5,000–8,000 patients, with nearly 55%–65% of patients having a relapsing-remitting MS subtype of the disease. The aim of this review is to provide an overview of current and emerging treatments available in Argentina for patients with MS.

Ejemplares similares